Moderna Says Omicron-Specific Booster Should Be Ready by August
Moderna Inc announced that the revamped COVID-19 booster shot to fight omicron and its subvariants should be ready by August.
COVID19 Vaccine
Fourth Dose of BNT162b2 Prevents Severe COVID-19 in Nursing Home Residents
For long-term care facility residents, a fourth dose of BNT162b2 COVID-19 vaccine confers substantial protection against COVID-19 hospitalization and deaths during an omicron surge.
COVID-19 Vaccine Does Not Increase CV Event Risk in Those With Existing Disease
There is no evidence of an increased risk for MACE after vaccination with BNT162b2 or CoronaVac in patients with CVD.
CDC Backs Moderna Vaccine for Those Aged 6 to 17
US CDC Director Rochelle Walensky, MD, signed off on the Moderna COVID-19 vaccine for children ages 6 through 17 years.
Primary Care Outreach Boosts COVID-19 Vaccination Rates
PCP outreach using electronic and mailed messages increases COVID-19 vaccination rates among older Black and Latino adults.
Text Messaging Intervention Does Not Improve COVID-19 Vaccine Uptake
No increase was seen in COVID-19 vaccination uptake with a text messaging intervention compared with telephone calls only, or for behaviorally informed message content.
COVID-19 Infection, Vaccination May Unmask Underlying Neuroinflammatory Conditions
A case study presented at the 2022 CMSC Annual Meeting reviews a 47-year-old male patient who experienced relapsing steroid-responsive encephalomyelitis after SARS-CoV-2 infection and subsequent COVID-19 infection.
Ofatumumab for Multiple Sclerosis Does Not Increase COVID-19 Severity
Presenting at CMSC 2022, researchers evaluated COVID-19 outcomes among patients with MS who received treatment with ofatumumab.
Humoral Response to COVID-19 mRNA Vaccine in Patients With MS Receiving DMTs
Presenting at CMSC 2022, researchers evaluated the response to the mRNA-1273 vaccine in patients who received DMTs for MS.
Lower Risk of COVID-19 in Infants With Vaccination During Pregnancy
Infants of mothers who received the second or third dose of COVID-19 vaccine during pregnancy have a lower risk of COVID-19 during the first four months of life, with lower risk during the delta variant-dominated period.
- Loading...
Loading...
Next post in General Medicine
Loading... 
Loading...